RICERCA ITALIANA     

FIRB simili:

• 1 - Identificazione ed analisi funzionale delle alterazioni molecolari e geniche che caratterizzano i tumori della mammella ormono-responsivi
• 2 - GENOMICA FUNZIONALE DELLE MALATTIE MUSCOLARI E CARDIACHE. RICERCA DI NUOVI MARCATORI MOLECOLARI E DI NUOVI BERSAGLI PER LA TERAPIA
• 3 - Sviluppo di strategie per l'analisi funzionale del genoma
• 4 - GENOTOPO:Genomica funzionale del topo
• 5 - Nuovi approcci integrati per l'identificazione di geni bersaglio in genomi eucarioti
• 6 - Identificazione e validazione di meccanismi genetico-molecolari coinvolti nel trasporto tubulare renale del sodio nell'ipertensione e nelle sue complicanze d'organo.
• 7 - Identificazione di profili genomici nucleo-mitocondriali nella patogenesi di malattie comuni età-associate. Implicazioni diagnostiche e terapeutiche.
• 8 - IDENTIFICAZIONE DI DETERMINANTI GENETICI DI SUSCETTIBILITA' IN MALATTIE MULTIFATTORIALI NELLA POPOLAZIONE ITALIANA
• 9 - Profili di espressione genica nell'iniziazione e progressione tumorale: correlazione con indicatori prognostici e terapeutici
• 10 - ANALISI FUNZIONALE DI GENI PATOLOGICI IMPLICATI NEL MANTENIMENTO DELL'INTEGRITÀ DEL GENOMA

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • GENETICA MEDICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

Classificazione geografica

• Regione: Liguria

Bibliografia

Acquati F et al. Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27. Oncogene 2001,20:980
Aitken J et al. CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst 1999;91:446
Auroy M et al. Clinically Sporadic Multiple Primary Melanoma Cases: Founder Mutation With Low Penetrance. Genes Chromosomes Cancer 2001 November (in press)
Bala S,Peltomaki P. CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res. 2001,61:6042
Benatti P et al. Clinical and biologic heterogeneity of hereditary nonpolyposis colorectal cancer. Int J Cancer 2001,95:323
Birch JM et al. Oncogene 1998,17:1061
Birch JM et al. Oncogene 2001,20:4621
Buermeyer AB et al. Mammalian DNA mismatch repair. Annu Rev Genet 1999;33:533
Cambien F et al. Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet,65:183-191,1999.
Campomenosi P et al. Oncogene 2001,20:3573
Canzian F et al. Construction of a phylogenetic tree for inbred strains of rat by arbitrarily primed polymerase chain reaction (AP-PCR). Mamm Genome 1995;6:231
Ciotti P et al. A Single Genetic Origin for the G101W CDKN2A Mutation in 20 Melanoma-Prone Families. Am J Hum Genet 2000;67(2).
Cohen-Kaminski S et al. EMBO J 1998;17:5151
Cortesina G et al. STAGING OF HEAD AND NECK SQUAMOUS CELL CARCINOMA USING THE MET ONCOGENE PRODUCT AS MARKER OF TUMOUR CELLS IN LYMPH NODE METASTASES. Int J Cancer 2000;89:286
De Gregorio et al. Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma. Int.J.Cancer 1998;79:269
De Miglio MR et al. Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain. Hepatology 2001;33:1110
De Miglio MR et al. Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10. Cancer Res 1999;59:4651
De Miglio MR et al. Mol Carcinog. 1999;25:21
Di Renzo MF et al. SOMATIC MUTATIONS OF THE MET ONCOGENE ARE SELECTED DURING METASTATIC SPREAD OF HUMAN HNSC CARCINOMAS. Oncogene 2000;19:1547
Dragani TA et al. Population-based Mapping of Pulmonary Adenoma Susceptibility 1 (PAS1) locus. Cancer Res 2000;60: 5017
Dragani TA et al. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res 1991;51:6299
Eaves IA et al. The genetically isolated populations of Finland and sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet 2000;25:32
Eeles RA,Ponder BAJ,Easton DF,Horwich A (Editors). Genetic Predisposition to Cancer. Chapman & Hall Medical, London 1996; pp 1-407.
Fearnhead NS et al. The ABC of APC. Hum Molec Genet 2001;10:721
Federico M et al. Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal. Breast Cancer Res Treat 1999;55:213
Feo F et al. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies. Crit Rev Oncog 2000;11:19
Gariboldi M et al. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat Genet 1993;3:132
Gayther SA et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 1995;11:428
Gayther SA et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 1997;15:103
Genuardi M et al. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer 1998;75:835
Ghiorzo P et al. Characterization of Ligurian Melanoma families and risk of other neoplasia incidence. Int J Cancer 1999,83:441
Giachino C et al. Eur. J Immunol 1998,28:3506
Harland M et al. Mutation Screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer 2000 May:45
Houlston RS,Tomlinson IPM.Polymorphisms and colorectal tumor risk. Gastroenterology 2001;121:282
Inga A. et al. Carcinogenesis 1997,18:2019
Inga A et al. Oncogene 1997,14:1307
Inga A et al. Oncogene 2001,20:501
Jones-Bolin SE et al. Effect of promoter and intron 2 polymorphisms on murine lung K-ras gene expression. Carcinogenesis 1998. 19:1503
Kelly J et al. J Biol Chem 1999,274:18327
Kim GD et al. JBC 274:31127,1999
Lantelme E et al. Eur J Immunol 2000,30:1520
Lavin,M. F.,and Y. Shiloh. Ann Rev Immunol 1997,15:177
Liao M-J,Van Dyke T. Genes & Dev 1999,13:1246,
Malkinson,A.M. The genetic basis of susceptibility to lung tumors in mice. Toxicology 1989,54:241
Manenti G et al. Linkage disequilibrium and physical mapping of Pas1 in mice. Genome Res 1999,9:639
Manenti G. et al. Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. Carcinogenesis 1997,18:1917
Mantelli M et al. High prevalence of the Gly101Trp germline mutation in the CDKN2A (P16INK4a) gene in 62 small Italian malignant melanoma families. Am J Med Genet 2001 (in press).
Maurici D et al. Oncogene 2001,20:3533
Menin C et al. Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett 2001,168:31-36.
Montagna M et al. Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res 1996,56:5466
Montagna M et al. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene 1999;18:4160
Monzon J et al. CDKN2A mutations in multiple primary melanomas. N Engl J Med 1998;338:879
Natali PG et al. OVEREXPRESSION OF THE MET/HGF RECEPTOR IN RENAL CELL CARCINOMAS. Int J Cancer 1996;69:212,
Nathanson KL,Weber BL. Other breast cancer susceptibility genes: searching for more holy grail. Hum Mol Genet 2001;10:715
Nussenzweig, M C Cell 1998,95:875,
Offit K . Clinical Cancer Genetics. Risk Counselling and Management. Wiley-Liss,New York 1998;pp 1-420.
Olivero M et al. OVEREXPRESSION AND ACTIVATION OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR IN HUMAN NON-SMALL CELL LUNG CARCINOMAS. Br J Cancer 1996;74:1862
Olivero M et al. NOVEL MUTATION IN THE ATP-BINDING SITE OF THE MET ONCOGENE TYROSINE KINASE IN A HPRCC FAMILY. Int J Cancer 1999;82:640
Pascale RM et al. Carcinogenesis 1996;17:1765
Pascale RM et al. Int J Cancer 1996;68:136
Pedroni M et al. Microsatellite instability in multiple colorectal tumors. Int J Cancer 1999;81:1
Peltomaki P. Human Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Molec Genet 2001,10:735
Petiniot L. et al. Proc. Natl. Acad. Sci. USA 2000,97:6664,
Phelan CM et al. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet 1996;12:309.
Ponder BAJ, Editor (1994). Genetics of Malignant Disease. Churchill Livingstone,Edinburgh. British Medical Bullettin 50:517-752.
Rabbitts,T. H. Nature 1994;372:143
Rebbeck TR et al. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 1999;64:1371
Savelyeva L et al. An interstitial tandem duplication of 9p23-24 coexists with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer. Cancer Res 58:863
Sellers TA et al. Lung cancer detection and prevention: Evidence for an interaction between smoking and genetic predisposition. Cancer Res 1992;52:2694s
van Gent DC et al. Nat Rev Genet 2001;2:196
Varley JM et al. Am J Hum Genet 1999;65:995
Walker GJ et al. Functional reassessment of p16 variants using a transfection-based assay. Int J Cancer 1999;82:305
Welcsh PL,King MC. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 2001;10:705
Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000;...

Parole Chiave

Tumori ereditari; Geni di suscettibilità ai tumori; Tumore ereditario del seno-ovario; Tumore colorettale ereditario; Melanoma familiare; Carcinoma epatocellulare